So, What is Kids In The House Anyway?
If you have been following JDRF across our social channels, or have been speaking to any of our diligent advocates, you may have heard of Kids in the House. Curious as to what it is? And how you can support? Then read on!
What is Kids in the House?
Kids in the House is the highlight of our advocacy program, where over 100 kids (and adults!) with type 1 diabetes visit Parliament House in Canberra to remind their MP that research is the key to a cure. It is the culmination of many months of work from our advocates who have met their local MP in their electorate, and asked them to promise to remember type 1 diabetes when it comes to supporting and funding medical research. Kids in the House is an opportunity to reconnect with these MPs and show them why this is so important
What are we asking for at Kids in the House?
We are asking both sides of politics to commit to continue funding the JDRF-led Type 1 Diabetes Clinical Research Network (CRN). This funding will ensure world-class research takes place in Australia, that Australians living with type 1 diabetes can access trials and that treatments can go from the lab to being safe and effective for people.
How will we show this?
Alongside showing the power of the community coming together to deliver this message to their elected representatives, we will be delivering the reality of living with type 1 diabetes. We’ll be doing this through some different, creative ways, but you’ll need to come back to the JDRF blog on Thursday to check them out.
What can we do to support?
On Thursday, check our social media profiles and website for stories and (a secret surprise we’re pretty excited about!) then share them across your channels, using the #kidsinthehouse tag.
Report: Aussie adults with type 1 diabetes unable to access life-changing technology due to high cost
Young adults and low-income families with type 1 diabetes (T1D) are facing immense barriers to using and retaining vital technology to manage their disease, with inequitable access and high costs putting them at risk of financial burden and life-threatening complications. The financial burden of managing T1D is exacerbating mental health issues with half of those […]
T1D Research Roundup: March 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Monash University researchers crack the […]
COVID-19 Vaccines and T1D: Answering Your Questions
Australia has begun the rollout of two COVID-19 vaccines — one from Pfizer, and one from AstraZeneca. Both these vaccines are safe and effective at protecting people against COVID-19, and all Australians are encouraged to get vaccinated. With vaccines beginning to be offered to people with T1D, we’ve gathered all the information you need to […]
Top 10 T1D Research Breakthroughs of 2020
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission to cure, treat and prevent T1D – including new insights into what causes the disease, some incredible results from prevention therapies, and the launch of […]